Recent Changes in the Patterns of Breast Cancer as a Proportion of All Deaths According to Race and Ethnicity
- PMID: 34172689
- PMCID: PMC8478795
- DOI: 10.1097/EDE.0000000000001394
Recent Changes in the Patterns of Breast Cancer as a Proportion of All Deaths According to Race and Ethnicity
Abstract
Background: Recent reports suggest that racial differences in breast cancer incidence rates have decreased. We examined whether these findings apply to breast cancer mortality while considering age, period, and cohort influences on both absolute and relative measures of breast cancer mortality.
Methods: Using publicly available datasets (CDC WONDER, Human Mortality Database), we developed an age-period-cohort model of breast cancer mortality and breast cancer deaths as a proportion of all deaths during 1968-2019 among all women and by 5 race/ethnicity groups with sufficient numbers for estimation: Hispanic (all races), American Indian/Alaska Native and Asian/Pacific Islanders (regardless of ethnicity), non-Hispanic Black, and non-Hispanic White.
Results: Initially increasing after 1968, age-adjusted breast cancer mortality rates have decreased among all racial/ethnic groups since 1988. The age-adjusted percent of all deaths due to breast cancer also has been declining for non-Hispanic White women since about 1990 while increasing or holding steady for other race/ethnic groups. In 2019, the age-adjusted percent of deaths due to breast cancer for women was highest for Asian/Pacific Islanders (5.6%) followed by non-Hispanic Black (4.5%), Hispanic (4.4%), non-Hispanic White (4.1%), and American Indian/Alaska Native women (2.6%).
Conclusions: Breast cancer mortality disparities are now greater on both relative and absolute scales for non-Hispanic Black women, and using the relative scale for Asian/Pacific Islander and Hispanic women, compared with non-Hispanic White women for the first time in 50 years.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors report no conflicts of interest.
Figures





Similar articles
-
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.JAMA Oncol. 2023 May 1;9(5):700-704. doi: 10.1001/jamaoncol.2022.7835. JAMA Oncol. 2023. PMID: 36862439 Free PMC article.
-
Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.JAMA Netw Open. 2023 Apr 3;6(4):e238893. doi: 10.1001/jamanetworkopen.2023.8893. JAMA Netw Open. 2023. PMID: 37074714 Free PMC article.
-
Associations between race and ethnicity and perioperative outcomes among women undergoing hysterectomy for adenomyosis.Fertil Steril. 2024 Jun;121(6):1053-1062. doi: 10.1016/j.fertnstert.2024.02.003. Epub 2024 Feb 10. Fertil Steril. 2024. PMID: 38342374
-
Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications: A Systematic Review.JAMA Health Forum. 2024 Jun 7;5(6):e241388. doi: 10.1001/jamahealthforum.2024.1388. JAMA Health Forum. 2024. PMID: 38848090 Free PMC article.
-
Disparities in breast cancer incidence across racial/ethnic strata and socioeconomic status: a systematic review.J Natl Med Assoc. 2008 Jul;100(7):833-9. doi: 10.1016/s0027-9684(15)31378-x. J Natl Med Assoc. 2008. PMID: 18672561
Cited by
-
Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity.Cancer Causes Control. 2025 May 6:10.1007/s10552-025-02006-2. doi: 10.1007/s10552-025-02006-2. Online ahead of print. Cancer Causes Control. 2025. PMID: 40327212 Free PMC article.
-
Population simulation modeling of disparities in US breast cancer mortality.J Natl Cancer Inst Monogr. 2023 Nov 8;2023(62):178-187. doi: 10.1093/jncimonographs/lgad023. J Natl Cancer Inst Monogr. 2023. PMID: 37947337 Free PMC article.
-
Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.J Gen Intern Med. 2024 Feb;39(3):428-439. doi: 10.1007/s11606-023-08518-4. Epub 2023 Nov 27. J Gen Intern Med. 2024. PMID: 38010458 Free PMC article.
-
Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer.J Clin Oncol. 2023 Feb 1;41(4):859-870. doi: 10.1200/JCO.22.01342. Epub 2022 Dec 1. J Clin Oncol. 2023. PMID: 36455167 Free PMC article.
-
"We adjusted for race": now what? A systematic review of utilization and reporting of race in American Journal of Epidemiology and Epidemiology, 2020-2021.Epidemiol Rev. 2023 Dec 20;45(1):15-31. doi: 10.1093/epirev/mxad010. Epidemiol Rev. 2023. PMID: 37789703 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70(1):7–30. - PubMed
-
- DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 2017;67(6):439–448. - PubMed
-
- Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 2009;18(1):121–31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical